CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
0.108
-0.002 (-1.82%)
At close: Dec 20, 2024, 4:00 PM
0.112
+0.004 (4.07%)
After-hours: Dec 20, 2024, 7:59 PM EST
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $6.21 million as of December 20, 2024. Its market cap has decreased by -43.67% in one year.
Market Cap
6.21M
Enterprise Value
-733.37K
1-Year Change
-43.67%
Ranking
Category
Stock Price
$0.11
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $71.80M to $6.21M, a decrease of -91.35%. That is a compound annual growth rate of -38.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 6.21M | -6.86% |
| Dec 29, 2023 | 6.67M | 108.14% |
| Dec 30, 2022 | 3.20M | -83.67% |
| Dec 31, 2021 | 19.61M | -52.32% |
| Dec 31, 2020 | 41.13M | -36.70% |
| Dec 31, 2019 | 64.97M | -9.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 6.60M |
| Portage Biotech | 6.56M |
| Syra Health | 6.44M |
| Bio-Path Holdings | 6.42M |
| ABVC BioPharma | 6.34M |
| IM Cannabis | 6.23M |
| PainReform | 6.21M |
| Addex Therapeutics | 6.16M |